Dinaciclib is a Novel Cyclin Dependent Kinase Inhibitor with Significant Clinical Activity in Relapsed and Refractory Chronic Lymphocytic Leukemia
暂无分享,去创建一个
Jeffrey A Jones | M. Grever | J. Byrd | A. Johnson | L. Andritsos | J. Flynn | S. Jaglowski | Honghong Zhou | Da Zhang | Yali Zhu | K. Small | R. Bannerji | K. Maddocks | J. Hessler | Im Ellie